The top emerging pharmaceutical companies in the US
While big pharma holds a sizable stake in the healthcare sector, several biotechs and mid-sized pharma companies fuel both the…
While big pharma holds a sizable stake in the healthcare sector, several biotechs and mid-sized pharma companies fuel both the…
February’s announcement that Novo Nordisk was partnering with a biotech developing molecular glues to treat rare diseases was the latest in a series of expensive deals hoping to utilise the…
In May 2023, pharma giant Eli Lilly looked as if it was onto a winner after publishing positive topline data from the Phase III TRAILBLAZER-ALZ 2 trial of its Alzheimer’s…
In the last few years, multimillion dollar revenues driven by popular demand, and even higher projections for the future have catapulted obesity drugs into the mainstream. In this month’s cover…
Tuberculosis or TB is the leading cause of death in people with HIV. Moreover, people living with HIV are at a 14–18 times higher risk of developing active TB compared…
Counterfeit drug production and distribution has increased in recent years. Disruption from the Covid-19 pandemic, business resilience impacts, and rapid technological development have prompted a wave of fake medications entering…
As patient organisations play a part in regulatory issues and contribute to health institutions’ guideline development, recent research finds many of these may have financial conflicts of interest (COI) and…